Congress should reconsider breaking up pharmacy benefit managers, experts say
Many popular proposals to reform the PBM industry are missing the forest for the trees, drug market experts said this week in Washington, D.C. Instead, Congress should go after the root issue: the oligopoly enjoyed by the Big Three PBMs.